SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

81,028.02 1,718.01
( 2.17%)

Global Indices

Nasdaq

51,462.04 -82.02
(-0.16%)

Dow Jones

7,424.83 50.10
(0.68%)

Hang Seng

57,293.47 -3,784.43
(-6.20%)

Nikkei 225

10,662.59 -120.07
(-1.11%)

Forex

USD-INR

94.41 -0.18
(-0.19%)

EUR-INR

106.07 -0.23
(-0.22%)

GBP-INR

127.18 -0.23
(-0.18%)

JPY-INR

0.60 0.00
(-0.04%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Garodia Chemical Ltd

Industry : Trading

BSE Code

ISIN Demat

Book Value()

530161

INE236P01010

8.879542

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

0.97

7.68

EPS(TTM)

Face Value()

Div & Yield %

Back

royal india corporation ltd

Fischer Medical Ventures consolidated net profit declines 22.02% in the June 2026 quarter

Aug 15,2026

Net profit of Fischer Medical Ventures declined 22.02% to Rs 3.79 crore in the quarter ended June 2026 as against Rs 4.86 crore during the previous quarter ended June 2025. Sales rose 249.49% to Rs 81.92 crore in the quarter ended June 2026 as against Rs 23.44 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	81.92	23.44	249
OPM %	13.75	17.02	-
PBDT	9.19	10.80	-15
PBT	7.83	10.03	-22
NP	3.79	4.86	-22

81,028.02 1,718.01 ( 2.17%)

51,462.04 -82.02 (-0.16%)

7,424.83 50.10 (0.68%)

57,293.47 -3,784.43 (-6.20%)

10,662.59 -120.07 (-1.11%)

94.41 -0.18 (-0.19%)

106.07 -0.23 (-0.22%)

127.18 -0.23 (-0.18%)

0.60 0.00 (-0.04%)